BPC-157 (Body Protection Compound-157) represents one of the most extensively studied peptides in preclinical research contexts. This pentadecapeptide, derived from a protective protein found in gastric juice, has been the subject of numerous laboratory investigations examining its effects in various experimental models. This review synthesizes published research findings while maintaining appropriate context regarding the compound’s research-only status.
Molecular Characteristics
BPC-157 is a synthetic peptide consisting of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. The compound is derived from a larger protein identified in human gastric juice, known as Body Protection Compound. Researchers have investigated this stable peptide fragment for its properties in various experimental systems.
Key molecular properties include:
- Molecular weight: approximately 1419 Da
- Water solubility enabling various administration routes in research
- Stability under physiological pH conditions
- Resistance to degradation compared to many peptides
Gastrointestinal Research
Given its origin from gastric tissue, BPC-157 has been extensively studied in gastrointestinal research models:
Gastric Lesion Models
Multiple studies have investigated BPC-157 in experimental models of gastric damage. Research published in peer-reviewed journals has examined the peptide’s effects in various stress-induced and chemically-induced gastric lesion models in rodents. These studies have characterized dose-response relationships and timing parameters.
Intestinal Research
Researchers have also examined BPC-157 in models involving intestinal tissue. Published studies have investigated the peptide in experimental models of intestinal anastomosis, inflammatory bowel conditions, and other gastrointestinal research contexts.
Musculoskeletal Research
A significant body of preclinical research has examined BPC-157 in musculoskeletal contexts:
Tendon Research Models
Multiple research groups have published studies examining BPC-157 in tendon injury models. These investigations have used various experimental approaches including transection models, crush injury models, and detachment-reattachment protocols in rodent subjects.
Muscle Tissue Studies
Research has examined BPC-157 in experimental muscle injury models. Published studies have investigated the peptide’s effects following induced muscle damage in laboratory animals, examining tissue responses over various timeframes.
Bone Research
Some investigators have examined BPC-157 in bone-related research contexts, including fracture tissue-related research models and bone-tendon junction studies in experimental animals.
Vascular Research
BPC-157 has been studied in various vascular research contexts:
Angiogenesis Studies
Research has examined BPC-157’s effects on blood vessel formation in experimental models. Studies using CAM (chorioallantoic membrane) assays and other angiogenesis research systems have been published.
Vascular Function Research
Investigators have examined the peptide’s interactions with vascular systems, including research on endothelial function and blood flow in experimental models.
Mechanism Research
Researchers have investigated potential mechanisms underlying observed effects:
Growth Factor Interactions
Studies have examined relationships between BPC-157 and various growth factors in experimental systems. Research has investigated potential interactions with growth factor signaling pathways.
Nitric Oxide System
Multiple publications have examined BPC-157’s interactions with nitric oxide (NO) systems. Research has investigated potential modulation of NO synthase activity and related pathways.
Dopaminergic System
Some research has examined BPC-157 in contexts related to dopamine systems, including studies in experimental models of dopaminergic dysfunction.
Research Considerations
Administration Routes in Research
Published studies have employed various administration routes including:
- Intraperitoneal injection (most common in rodent studies)
- Local/topical application
- Oral administration (investigating stability)
- Intragastric delivery
Dosing in Experimental Models
Research has employed various dosing protocols, typically reported in micrograms per kilogram body weight in animal studies. Published research has examined dose-response relationships across wide concentration ranges.
Literature Overview
BPC-157 research has been published in numerous peer-reviewed journals over several decades. The majority of published work originates from research groups in Europe, with studies appearing in journals covering gastroenterology, pharmacology, and experimental compound.
Researchers interested in BPC-157 should consult primary literature through databases such as PubMed for detailed methodologies and findings from specific studies.
Research Peptide Specifications
For laboratory research applications, BPC-157 is typically supplied as:
- Lyophilized powder form
- Purity specifications of 98%+ by HPLC
- Mass spectrometry-confirmed molecular weight
- Accompanied by Certificate of Analysis
Quality Assurance and Documentation
YourPeptideBrand provides research-grade BPC-157 manufactured to rigorous quality standards. Each batch includes comprehensive documentation including HPLC purity analysis, mass spectrometry confirmation, and complete Certificate of Analysis. Our BPC-157 is intended for Research Use Only and has been examined in studies regarding investigators requiring well-characterized peptide compounds.
Disclaimer: This content is provided for informational and research purposes only. All products referenced are intended for Research Use Only (RUO) and are not intended for human consumption or for use in the research identification, research application, research focus, mitigation, or supports healthy function. Not for human consumption.
